• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[REACH注册研究对内分泌科医生的启示]

[Implications of the REACH registry for endocrinologists].

作者信息

Alonso Guillermo

机构信息

Hospital Universitario San Cecilio, Granada, España.

出版信息

Med Clin (Barc). 2009 Sep;132 Suppl 2:21-4. doi: 10.1016/S0025-7753(09)71748-8.

DOI:10.1016/S0025-7753(09)71748-8
PMID:19631834
Abstract

Diabetes mellitus is a major public health problem due to its increasing incidence in the general population and the morbidity and mortality associated with micro- and macrovascular complications. Patients with diabetes have a 2-5-fold increased risk of coronary heart disease, stroke and peripheral artery disease. The REACH registry is the largest observational study in the world designed to assess prognostic and therapeutic data in the population with elevated risk for atherothrombotic events. The results of this study show a high prevalence of obesity, diabetes mellitus and metabolic syndrome in the population with increased cardiovascular risk. Moreover, the data demonstrate that metabolic control of diabetes mellitus is clearly inadequate. Data from the REACH registry show endocrinologists and diabetologists that a multidisciplinary approach is imperative and that adequate management of diabetic patients should include stratification of cardiovascular risk, including assessment of associated conditions such as obesity, hypertension, dyslipidemia, microalbuminuria and smoking.

摘要

糖尿病是一个重大的公共卫生问题,这是由于其在普通人群中的发病率不断上升,以及与微血管和大血管并发症相关的发病率和死亡率所致。糖尿病患者患冠心病、中风和外周动脉疾病的风险增加2至5倍。REACH注册研究是世界上最大的观察性研究,旨在评估动脉粥样硬化血栓形成事件风险升高人群的预后和治疗数据。这项研究的结果显示,在心血管风险增加的人群中,肥胖、糖尿病和代谢综合征的患病率很高。此外,数据表明糖尿病的代谢控制明显不足。REACH注册研究的数据向内分泌科医生和糖尿病专家表明,多学科方法势在必行,糖尿病患者的充分管理应包括心血管风险分层,包括评估肥胖、高血压、血脂异常、微量白蛋白尿和吸烟等相关情况。

相似文献

1
[Implications of the REACH registry for endocrinologists].[REACH注册研究对内分泌科医生的启示]
Med Clin (Barc). 2009 Sep;132 Suppl 2:21-4. doi: 10.1016/S0025-7753(09)71748-8.
2
[Implications of the REACH registry for cardiologists].[REACH注册研究对心脏病专家的意义]
Med Clin (Barc). 2009 Sep;132 Suppl 2:15-20. doi: 10.1016/S0025-7753(09)71747-6.
3
[One-year data from the REACH registry in Spain].[来自西班牙REACH注册研究的一年期数据]
Med Clin (Barc). 2009 Sep;132 Suppl 2:10-4. doi: 10.1016/S0025-7753(09)71746-4.
4
[Implications of the REACH registry for vascular surgery].[REACH注册研究对血管外科的意义]
Med Clin (Barc). 2009 Sep;132 Suppl 2:25-9. doi: 10.1016/S0025-7753(09)71749-X.
5
[Implications of the REACH registry for internal medicine].[《化学品注册、评估、授权和限制制度》登记册对内科医学的影响]
Med Clin (Barc). 2009 Sep;132 Suppl 2:34-7. doi: 10.1016/S0025-7753(09)71751-8.
6
[Implications of the REACH registry for neurologists].[REACH注册研究对神经科医生的启示]
Med Clin (Barc). 2009 Sep;132 Suppl 2:30-3. doi: 10.1016/S0025-7753(09)71750-6.
7
[Use of drugs in the REACH registry: from guidelines to clinical practice].[在REACH注册研究中药物的使用:从指南到临床实践]
Med Clin (Barc). 2009 Sep;132 Suppl 2:44-6. doi: 10.1016/S0025-7753(09)71754-3.
8
[The REACH registry: baseline and 1-year results].[REACH注册研究:基线和1年结果]
Med Clin (Barc). 2009 Sep;132 Suppl 2:5-9. doi: 10.1016/S0025-7753(09)71745-2.
9
[Optimizing overall risk reduction: implications of the REACH registry. Introduction].[优化总体风险降低:REACH注册研究的启示。引言]
Med Clin (Barc). 2009 Sep;132 Suppl 2:1. doi: 10.1016/s0025-7753(09)71743-9.
10
[Pharmacoeconomic analysis: results of the REACH registry].[药物经济学分析:REACH注册研究结果]
Med Clin (Barc). 2009 Sep;132 Suppl 2:41-3. doi: 10.1016/S0025-7753(09)71753-1.